![]() |
Volumn 27, Issue 1, 2009, Pages 156-157
|
Erythema multiforme/stevens-johnson syndrome/toxic epidermal necrolysis in lenalidomide-treated patients
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
ALLOPURINOL;
BORTEZOMIB;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
IMATINIB;
LENALIDOMIDE;
LEVOFLOXACIN;
MOXIFLOXACIN;
QUINOLONE DERIVATIVE;
RITUXIMAB;
TAMOXIFEN;
THALIDOMIDE;
TRIMETHOPRIM;
ADULT;
AGED;
AMYLOIDOSIS;
BLISTER;
CLINICAL FEATURE;
DIAGNOSTIC ERROR;
DRUG DOSE REDUCTION;
DRUG ERUPTION;
DRUG INDICATION;
DRUG INDUCED DISEASE;
DRUG SAFETY;
DRUG WITHDRAWAL;
DYSPHAGIA;
ERYTHEMA;
ERYTHEMA MULTIFORME;
FEMALE;
HOSPITAL ADMISSION;
HUMAN;
INCIDENCE;
LETTER;
MACULOPAPULAR RASH;
MALE;
MEDICAL INFORMATION;
MORTALITY;
MOUTH PAIN;
MULTIPLE MYELOMA;
PRIORITY JOURNAL;
PRURITUS;
SKIN BIOPSY;
STEVENS JOHNSON SYNDROME;
SWELLING;
TOXIC EPIDERMAL NECROLYSIS;
URTICARIA;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
EPIDERMAL NECROLYSIS, TOXIC;
ERYTHEMA MULTIFORME;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
STEVENS-JOHNSON SYNDROME;
THALIDOMIDE;
|
EID: 58149343983
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2008.20.3737 Document Type: Letter |
Times cited : (30)
|
References (8)
|